GILEAD SCIENCES, INC.

GILD
Biological products no disgnostic substances
Last filing · Annual · Dec 31, 2025
Financial Statements Ratios
Export XLSX
Period
Annual Quarterly
Order

14 more years with Pro

GILEAD SCIENCES, INC. back to 2009, every line as filed.

Create a free account
RatiosDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010Dec 31, 2009
Gross Margin
78.83%
78.26%
76.04%
Operating Margin
34.04%
5.78%
28.05%
Pretax Margin
33.27%
2.40%
25.30%
Effective Tax Rate
13.13%
30.58%
18.18%
Net Margin
28.90%
1.67%
20.89%
Current Ratio
1.55x
1.60x
1.43x
Debt to Equity
1.61x
2.07x
1.73x
Net Debt to Equity
1.28x
1.55x
1.46x
Asset Turnover
49.88%
48.74%
43.65%
Return on Equity
37.62%
2.49%
24.90%
Return on Assets
14.42%
0.81%
9.12%
Operating Cash Flow Margin
34.03%
37.66%
29.53%
Cash Conversion
117.73%
2,255.83%
141.32%
Free Cash Flow Margin
32.12%
35.84%
27.37%